Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer

Published:2006 Issue:3 Volume:107 Page:599-605
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Yamamoto Nobuyuki,Nakagawa Kazuhiko,Uejima Hisao,Sugiura Takahiko,Takada Yoshiki,Negoro Shun-ichi,Matsui Kaoru,Kashii Tatsuhiko,Takada Minoru,Nakanishi Yoichi,Kato Terufumi,Fukuoka Masahiro

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

2. American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

3. Platinum-Based Versus Non-Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of the Published Literature

4. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

5. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of gemcitabine/carboplat in versus paclitaxel/cisplatin for the management of non small cell lung cancer;Tropical Journal of Pharmaceutical Research;2022-09-25

2. Quantitative comparison of the efficacies and safety profiles of three first-line non-platinum chemotherapy regimens for advanced non-small cell lung cancer;Frontiers in Pharmacology;2022-08-29

3. Correlations between objective response rate and survival-based endpoints in first-line advanced non-small cell lung Cancer: A systematic review and meta-analysis;Lung Cancer;2022-08

4. Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801;The Oncologist;2020-05-18

5. Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer;The Oncologist;2019-10-21